Bio-Techne Executive Compensation
Bio-Techne is a publicly traded company in the Healthcare sector.
Named Executive Officers — FY2024
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Bio-Techne discloses FY2024 compensation for 6 named executive officers, totaling $3.7M. Kim Kelderman, the President and CEO Former President Diagnostics and Genomics, accounts for 36% of that combined total.
Kim Kelderman's total compensation rose 362% year-over-year, from $285,394 in FY2023 to $1.3M in FY2024.
Among 78 other Healthcare companies in this dataset, Bio-Techne's combined tracked executive pay of $3.7M ranks in the 15th percentile (industry median: $13.6M). Its highest-paid executive, Kim Kelderman, ranks in the 14th percentile for top-executive pay in the sector (industry median: $6.3M).